首页> 美国卫生研究院文献>other >Whole-Exome Sequencing Identifies a Novel Genotype-Phenotype Correlation in the Entactin Domain of the Known Deafness Gene TECTA
【2h】

Whole-Exome Sequencing Identifies a Novel Genotype-Phenotype Correlation in the Entactin Domain of the Known Deafness Gene TECTA

机译:全外显子测序确定已知的耳聋基因TECTA的actactin域中的新型基因型-表型相关性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Postlingual progressive hearing loss, affecting primarily the high frequencies, is the clinical finding in most cases of autosomal dominant nonsyndromic hearing loss (ADNSHL). The molecular genetic etiology of ADNSHL is extremely heterogeneous. We applied whole-exome sequencing to reveal the genetic etiology of high-frequency hearing loss in a mid-sized Korean family without any prior linkage data. Whole-exome sequencing of four family members (two affected and two unaffected), together with our filtering strategy based on comprehensive bioinformatics analyses, identified 21 potential pathogenic candidates. Sanger validation of an additional five family members excluded 20 variants, leaving only one novel variant, TECTA c.710C>T (p.T237I), as the strongest candidate. This variant resides in the entactin (ENT) domain and co-segregated perfectly with non-progressive high-frequency hearing loss in the family. It was absent among 700 ethnically matched control chromosomes, and the T237 residue is conserved among species, which supports its pathogenicity. Interestingly, this finding contrasted with a previously proposed genotype-phenotype correlation in which variants of the ENT domain of TECTA were associated with mid-frequency hearing loss. Based upon what we observed, we propose a novel “genotype to phenotype” correlation in the ENT domain of TECTA. Our results shed light on another important application of whole-exome sequencing: the establishment of a novel genotype-phenotype in the molecular genetic diagnosis of autosomal dominant hearing loss.
机译:在大多数常染色体显性非综合征性听力损失(ADNSHL)病例中,临床发现是舌后进行性听力损失,主要影响高频。 ADNSHL的分子遗传病因极为不同。我们应用了全外显子组测序来揭示中型韩国家庭中高频听力损失的遗传病因,而没有任何先前的关联数据。四个家族成员(两个受影响和两个未受影响)的全外显子测序,加上我们基于全面生物信息学分析的过滤策略,确定了21个潜在的致病候选物。对另外5个家族成员的Sanger验证排除了20个变体,仅剩下一个新变体TECTA c.710C> T(p.T237I)作为最强候选者。此变体位于entactin(ENT)域中,与家族中非进行性高频听力损失完全共隔离。它在700个种族匹配的对照染色体中不存在,并且T237残基在物种之间是保守的,这支持了它的致病性。有趣的是,这一发现与先前提出的基因型-表型相关性相反,在基因型-表型相关中,TECTA ENT域的变体与中频听力损失相关。基于我们的观察,我们在TECTA的ENT域中提出了一种新颖的“基因型与表型”相关性。我们的结果为全外显子测序的另一个重要应用提供了启示:在常染色体显性遗传性听力损失的分子遗传学诊断中建立新的基因型-表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号